Small Molecules
Global Chemical Project
We are making advancements to secure our position as a leader in the global pharmaceutical sector through entry into the small molecule drugs segment that accounts for two-thirds of the global pharmaceutical market. We currently offer a wide variety of small molecules for treatment in various disease areas such as circulatory, endocrine, nervous, and tumor/immune systems to domestic and overseas markets. We plan to utilize our world-class R&D capabilities and stable product supply chain to enhance our market presence in the core treatment areas.Joint Project Process
For a successful global chemical project, we create synergies and increase business efficiency by dividing the business into two entities: as the headquarter of pharmaceutical business, Celltrion manages the overall business, while CelltrionPharm focuses on R&D and production.Planning
R&D
Process development
Clinical trial
Approval
Production
Distribution & sales
Celltrion
Celltrion Pharm
